Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer — Stella

Home/Breast Cancer (Early Breast Cancer)/

View on ClinicalTrials.gov

Recruiting

Back to Breast Cancer (Early Breast Cancer) trials

Trial locations(1 site)

France

Hôpital Saint-Louis, Paris

Key details

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment target

~1,000 participants

Started

June 2026

Primary completion

June 2031

Age range

18 Years and older

Sex

Female only

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.